Docteur MARINE FAUNY

Bibliographie

• DXA evaluation of bone fragility 2 years after bariatric surgery in patients with obesity

  2024

  ArticleBone Reports

• Relationship between spinal structural damage on radiography and bone fragility on CT in ankylosing spondylitis patients

  2021

  ArticleScientific Reports

• Consequences of spinal ankylosis on bone trabecular fragility assessed on CT scans in patients with ankylosing spondylitis. A retrospective study

  2020

  ArticleJoint Bone Spine

• Faecal Calprotectin for the Diagnosis of Bowel Inflammation in Patients With Rheumatological Diseases: A Systematic Review

  2020

  ArticleJournal of Crohn's and Colitis

• Relationship between calcifications and structural lesions on hand radiography and axial calcifications on CT-scan

  2020

  ArticleMedicine

• Low Back Pain and Sacroiliitis on Cross-Sectional Abdominal Imaging for Axial Spondyloarthritis Diagnosis in Inflammatory Bowel Diseases

  2020

  ArticleInflammatory Intestinal Diseases

• Paradoxical gastrointestinal effects of interleukin-17 blockers

  2020

  ArticleAnnals of the Rheumatic Diseases

• Study of vertebral fracture and Scanographic Bone Attenuation Coefficient in rheumatoid arthritis and ankylosing spondylitis vs. controls

  2019

  ArticleScientific Reports

Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).

Lieux de consultation

• CHRU NANCY - HOPITAUX DE BRABOIS

  Rue DU MORVAN, 54511 Vandoeuvre-lès-Nancy

  ☎ 0383153030Hospitalier🏥 Voir cet établissement

• CENTRE HOSPITALIER SAINT CHARLES TOUL

  1 Cours RAYMOND POINCARE, 54201 Toul

  ☎ 0383622020Hospitalier🏥 Centre CH ↗🏥 Voir cet établissement

Tarifs & secteur de conventionnement

Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).

Prendre rendez-vous & contact

Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).

Top publications · les plus citées

• 1

  Paradoxical gastrointestinal effects of interleukin-17 blockers

  Annals of the rheumatic diseases · 2020

  📚 203 citations🎯 RCR 10.93Top 2% NIH🔓 Open Access📄 PDF gratuit ↗
• 2

  Opportunistic screening for osteoporosis using thoraco-abdomino-pelvic CT-scan assessing the vertebral density in rheumatoid arthritis patients

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2019

  📚 29 citations🎯 RCR 2.13Top 25% NIH
• 3

  Faecal Calprotectin for the Diagnosis of Bowel Inflammation in Patients With Rheumatological Diseases: A Systematic Review

  Journal of Crohn's & colitis · 2020

  📚 27 citations🎯 RCR 1.65

  Lire l'abstract Crossref ↓

  Abstract Background and Aims Endoscopic and histological gut inflammation are present in half of patients with ankylosing spondylitis [AS] or spondyloarthritis [SpA]. We performed a systematic literature review on the use of faecal calprotectin [FC] in patients with rheumatic diseases. Methods Searches of the PubMed, Web of Science, and Cochrane Library databases were performed up to September 2019 to identify all studies including adult patients with confirmed diagnosis of SpA or AS. Results Seven studies met the inclusion criteria: six prospective observational studies and one retrospective observational study. Study populations consisted of SpA patients in four studies and AS patients in three studies. In six studies, an ELISA test was used for FC levels and in one case, a semi-quantitative assay was adopted. In all included studies, patients with SpA or AS had elevated FC levels, ranging from 21.2% to 70.7% of patients. In six studies, patients with increased FC levels had macroscopic mucosal inflammation, ranging from 11% to 80% of cases. Four studies highlighted the presence of microscopic alterations in patients with high FC levels, ranging from 41.7% to 100% of patients. An FC cut-off level predicting the inflammatory bowel disease [IBD] occurrence was found in two studies: 266 mg/kg and 132 mg/kg, with sensitivity and specificity of 100%, 78.7% and 66.7%, 76.9%, respectively. Conclusions Faecal calprotectin is a useful and non-invasive marker to predict IBD in patients with SpA or AS. Gut histological and macroscopic mucosal inflammation were found in up to 100% and 80% of rheumatological patients with increased FC levels.

Publications scientifiques (16) — classées par pathologie

Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).

Partager cette fiche